Key takeaways
Zanamivir (Relenza) and rimantadine are both antiviral medications used to treat and prevent the flu, but they have some key differences. Zanamivir (Relenza) is a neuraminidase inhibitor effective against influenza types A and B, while rimantadine is only used against influenza type A. Zanamivir is inhaled through a Diskhaler, making it a good option for those who have trouble swallowing pills, but it is not recommended for people with asthma or COPD due to the risk of bronchospasm. Rimantadine is taken orally and is available as a generic, making it a more affordable option, but it is not recommended as a first-choice treatment due to resistance in many flu strains. Zanamivir is typically used for flu treatment in people aged 7 and older and for prevention in those aged 5 and older, while rimantadine is used for treatment in adults 17 years and older and for prevention in children as young as 1 year old. Common side effects of zanamivir include runny nose and dizziness, whereas rimantadine can cause nausea and trouble sleeping. Zanamivir should not be used within two weeks of receiving the FluMist vaccine.
